使用表观扩散系数参数映射量化儿童弥漫性内生性桥脑胶质瘤放疗反应:儿童脑肿瘤联盟报告
本研究基于儿童脑肿瘤联盟多中心队列,对95例弥漫性内生性桥脑胶质瘤(DIPG)患者的基线及放疗后MRI生成ADC参数映射图,最终72例纳入分析。结果显示基线ADC均值较高与无进展生存期延长相关(HR 0.27,95%CI 0.09-0.82,P=0.022),而放疗相关ADC变化指标与总生存期无显著关联。作者认为基线ADC值较放疗相关ADC变化是更强的预后预测因子,并展示了参数映射技术在多中心研究中量化空间异质性治疗反应的可行性。
要点
- 基线ADC均值较高与DIPG患者无进展生存期延长相关(HR 0.27,95%CI 0.09-0.82,P=0.022)。
- 放疗后fiADC较高者无进展生存期有缩短趋势(HR 6.44,95%CI 0.79-52.79,P=0.083)。
- fDM衍生指标与总生存期无显著关联。
核心结论
- 在儿童DIPG中,基线ADC值较放疗相关ADC变化是更强的结局预测因子。
- 参数映射技术可用于多中心研究量化儿童肿瘤(包括DIPG)的空间异质性治疗反应。
研究设计与样本
- 研究获取95例DIPG患者的基线及放疗后MR检查,基于T2/FLAIR和强化感兴趣区生成系列定量ADC参数映射图,最终72例纳入分析。
主要发现
- 基线至首次放疗时间点之间fiADC较高的肿瘤显示无进展生存期缩短趋势,风险比6.44(95%CI 0.79-52.79,P=0.083)。
- 基线log平均ADC较高的肿瘤无进展生存期较长,风险比0.27(95%CI 0.09-0.82,P=0.022)。
- fDM衍生指标与总生存期之间无显著关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Baseline diffusion or apparent diffusion coefficient (ADC) characteristics have been shown to predict outcome related to DIPG, but the predictive value of post-radiation ADC is less well understood. ADC parametric mapping (FDM) was used to measure radiation-related changes in ADC and compared these metrics to baseline ADC in predicting progression-free survival and overall survival using a large multi-center cohort of DIPG patients (Pediatric Brain Tumor Consortium-PBTC). MATERIALS AND METHODS: MR studies at baseline and post-RT in 95 DIPG patients were obtained and serial quantitative ADC parametric maps were generated from diffusion-weighted imaging based on T2/FLAIR and enhancement regions of interest (ROIs). Metrics assessed included total voxels with: increase in ADC (iADC); decrease in ADC (dADC), no change in ADC (nADC), fraction of voxels with increased ADC (fiADC), fraction of voxels with decreased ADC (fdADC), and the ratio of fiADC and fdADC (fDM Ratio). RESULTS: A total of 72 patients were included in the final analysis. Tumors with higher fiADC between baseline and the first RT time point showed a trend toward shorter PFS with a hazard ratio of 6.44 (CI 0.79, 52.79, p = 0.083). In contrast, tumors with higher log mean ADC at baseline had longer PFS, with a hazard ratio of 0.27 (CI 0.09, 0.82, p = 0.022). There was no significant association between fDM derived metrics and overall survival. CONCLUSIONS: Baseline ADC values are a stronger predictor of outcome compared to radiation related ADC changes in pediatric DIPG. We show the feasibility of employing parametric mapping techniques in multi-center studies to quantitate spatially heterogeneous treatment response in pediatric tumors, including DIPG.
引用
- Ceschin R, Kocak M, Vajapeyam S, et al. Quantifying radiation therapy response using apparent diffusion coefficient (ADC) parametric mapping of pediatric diffuse intrinsic pontine glioma: a report from the pediatric brain tumor consortium. J Neurooncol. 2019. PMID: 30810873. doi:10.1007/s11060-019-03133-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。